Medify, a provider of digital health assistant apps for patients, medical practitioners, and retail pharmacies, announced the closure of its $1 million seed funding round.
Authum Investment & Infrastructure led the investment round with participation from notable financial intermediaries and angel investors, including Global Media Ventures India, Advisory Members Sudeepto Deb, Partner at Sattva Consulting, and Dr. Vijay T. Shah, a Senior Interventional Cardiologist practicing in Mumbai.
With new funds, the startup plans to develop and commercialize its-to-end digital health assistant platform for (both) care providers and patients.
Commenting on the funding news announcement, Kairav Shah, Founder & CEO of Medify, said: “Despite millions worth of investments in this sector, operators of healthcare enterprises, whether micro, small or large, are still employing obsolete methods to maintain the information, security of access and retain their patients. At Medify, we aim to modernize this operation by providing secure cloud-based storage and access to relevant information and analytics for all Primary Healthcare Providers.”
Digital healthcare assistant apps
Digital healthcare assistant apps have secured approximately $500 million in funding to date, according to our database. The latest funding round in the digital health assistant space includes:
Wysa, an AI-powered digital mental health assistant, raised $20 million in Series B funding. HealthQuad led the investment round with participation from British International Investment (BII), the UK’s development finance institution, W Health Ventures, Kae Capital, Google Assistant Investments, and pi Ventures.
Homethrive, a healthcare navigation and assistant app for employees, employers, families, and insurers, raised $20 million in a Series B funding led by Human Capital with participation from Allianz, 7wireVentures, and Pitango HealthTech.
Overjet, an AI-powered dental assistant platform for care providers and payers, raised $42.5 million in Series B funding led by General Catalyst and Insight Partners with participation from returning investors Crosslink Capital and the MIT-affiliated E14 Fund.
